Figure 4 | Scientific Reports

Figure 4

From: Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer

Figure 4

Clinical characteristics and functional enrichment analyses in different risk groups. (A,B) Heatmap of core clinical characteristics in different risk groups in the training set (A) and the testing set (B). (C) GO analysis for biological process of identified DEGs in the training set. (D) KEGG analysis of identified DEGs in the training set. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Back to article page